142 related articles for article (PubMed ID: 1843092)
41. [Ascites. Diagnostic orientation and management].
Diaz D; Michel H
Rev Prat; 1990 Apr; 40(10):938-40. PubMed ID: 2326581
[No Abstract] [Full Text] [Related]
42. Peritoneal fluid lactate dehydrogenase in ovarian cancer.
Schneider D; Halperin R; Langer R; Bukovsky I; Herman A
Gynecol Oncol; 1997 Sep; 66(3):399-404. PubMed ID: 9299252
[TBL] [Abstract][Full Text] [Related]
43. [Diagnosis of neoplastic ascites: combined use of albumin gradient between serum and ascites and cholesterol in ascitic fluid].
Sartori M; Andorno S; Bermani G; Colombi S; Gambaro M; La Terra G; Leone F; Molinari GL; Aglietta M
Recenti Prog Med; 1996 Feb; 87(2):75-7. PubMed ID: 8725084
[No Abstract] [Full Text] [Related]
44. Ascites: diagnosis and management.
Hou W; Sanyal AJ
Med Clin North Am; 2009 Jul; 93(4):801-17, vii. PubMed ID: 19577115
[TBL] [Abstract][Full Text] [Related]
45. A multicenter, case-controlled study of the clinical presentation and etiology of ascites and of the safety and clinical efficacy of diagnostic abdominal paracentesis in HIV seropositive patients.
Cappell MS; Shetty V
Am J Gastroenterol; 1994 Dec; 89(12):2172-7. PubMed ID: 7977236
[TBL] [Abstract][Full Text] [Related]
46. (1)H NMR spectroscopy of ascitic fluid: discrimination between malignant and benign ascites and comparison of the results with conventional methods.
Bala L; Sharma A; Yellapa RK; Roy R; Choudhuri G; Khetrapal CL
NMR Biomed; 2008 Jul; 21(6):606-14. PubMed ID: 18205245
[TBL] [Abstract][Full Text] [Related]
47. Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.
Castaldo G; Oriani G; Cimino L; Topa M; Mostarda I; Castellano L; Del Vecchio-Blanco C; Budillon G; Salvatore F; Sacchetti L
Clin Chem; 1994 Mar; 40(3):478-83. PubMed ID: 8131285
[TBL] [Abstract][Full Text] [Related]
48. Nephrogenic ascites.
Craig R; Sparberg M; Ivanovich P; Rice L; Dordal E
Arch Intern Med; 1974 Aug; 134(2):276-9. PubMed ID: 4843195
[No Abstract] [Full Text] [Related]
49. [Differential diagnosis between exudate and transudate in pleural effusion].
Vázquez F; Michelángelo H; Trevisani H; González F; de Quiros B
Medicina (B Aires); 1996; 56(3):223-30. PubMed ID: 9035477
[TBL] [Abstract][Full Text] [Related]
50. Biochemical constituents of peritoneal fluid in cows.
Wittek T; Grosche A; Locher L; Alkaassem A; Fürll M
Vet Rec; 2010 Jan; 166(1):15-9. PubMed ID: 20045853
[TBL] [Abstract][Full Text] [Related]
51. [Evaluation of the biochemical parameters in the differential diagnosis of ascites].
de Oliveira e Silva A; Roldan-Molina F; D'Albuquerque LA
Arq Gastroenterol; 1991; 28(2):45-6. PubMed ID: 1843091
[No Abstract] [Full Text] [Related]
52. Value of ascitic fibronectin and cholesterol concentration in the differentiation between malignancy-related and non-malignant ascites.
Archimandritis A; Kapsalas D; Douvara M; Tjivras M; Tsirantonaki M; Fertakis A
Ann Med Interne (Paris); 1996; 147(3):145-50. PubMed ID: 8796090
[TBL] [Abstract][Full Text] [Related]
53. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites.
Runyon BA; Montano AA; Akriviadis EA; Antillon MR; Irving MA; McHutchison JG
Ann Intern Med; 1992 Aug; 117(3):215-20. PubMed ID: 1616215
[TBL] [Abstract][Full Text] [Related]
54. [Zinc in patients with ascites].
Gil Extremera B; Maldonado Martín A; Ruiz Martínez M; Bermúdez García JM; Muñoz Torres F; Maldonado Martín I
An Med Interna; 1989 Dec; 6(12):624-8. PubMed ID: 2562368
[TBL] [Abstract][Full Text] [Related]
55. [Clinico-chemical study of body cavity effusions].
Hirschberger J; Sauer UG
Tierarztl Prax; 1991 Aug; 19(4):431-4. PubMed ID: 1948992
[TBL] [Abstract][Full Text] [Related]
56. [Lactic dehydrogenase in the etiological diagnosis of serous effusions].
Valdés EF; Schere M; Perazzo L; Abelini O
Rev Clin Esp; 1967 Jan; 104(2):133-6. PubMed ID: 5596059
[No Abstract] [Full Text] [Related]
57. Pleural effusion: comparison of clinical judgment and Light's criteria in determining the cause.
Scheurich JW; Keuer SP; Graham DY
South Med J; 1989 Dec; 82(12):1487-91. PubMed ID: 2595416
[TBL] [Abstract][Full Text] [Related]
58. The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis.
Khandwalla HE; Fasakin Y; El-Serag HB
Am J Gastroenterol; 2009 Jun; 104(6):1401-5. PubMed ID: 19491852
[TBL] [Abstract][Full Text] [Related]
59. The mechanism of ascitic fluid protein concentration increase during diuresis in patients with chronic liver disease.
Hoefs JC
Am J Gastroenterol; 1981 Nov; 76(5):423-31. PubMed ID: 7337129
[TBL] [Abstract][Full Text] [Related]
60. [Evaluation of the usefulness of the physico-chemical study of ascitic fluid in patients with chronic hepatopathies, neoplasms and spontaneous peritonitis].
Olmos M; Martínez A; Raffo C; Valdez I; Mendelluk G; Orcinoli MT; Magnanini F
Acta Gastroenterol Latinoam; 1990; 20(3):145-58. PubMed ID: 2095098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
